Sorry forgot to add the link!
a snippet of the article
Some notable contracts that PCT has worked on include Dendreon’s (DNDN) PROVENGE product, (which got FDA approval) and a host of other firms in cell therapy manufacturing, from inception through clinical trial pathway. PCT participated in Dendreon’s approval by providing the majority of their Phase 3b products to patients on both the east and west coast and now Dendreon has an approved cell therapy. PCT did their Phase 1 and 2 work as well. Prima Biomed is another firm which PCT worked with. It's working on Phase 3 ovarian cancer drug using dendritic cells.
Or you can read the whole thing here
http://seekingalpha.com/article/297380-neostem-may-have-the-right-mix-of-assets-to-excel-in-cell-therapies
- Forums
- ASX - By Stock
- mention in seeking alpha
Sorry forgot to add the link! a snippet of the article Some...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
38.0¢ |
Change
0.010(2.70%) |
Mkt cap ! $551.9M |
Open | High | Low | Value | Volume |
37.0¢ | 39.0¢ | 37.0¢ | $1.296M | 3.401M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 54900 | 37.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
38.0¢ | 22008 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 2623 | 0.385 |
1 | 21052 | 0.380 |
2 | 54900 | 0.375 |
6 | 47736 | 0.370 |
3 | 108500 | 0.365 |
Price($) | Vol. | No. |
---|---|---|
0.355 | 1107 | 1 |
0.380 | 6375 | 1 |
0.385 | 50000 | 2 |
0.390 | 258081 | 7 |
0.395 | 166772 | 7 |
Last trade - 16.10pm 28/08/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
UNT
UNITH LTD
Idan Schmorak, CEO
Idan Schmorak
CEO
Previous Video
Next Video
SPONSORED BY The Market Online